Alleo Labs
- Biotech or pharma, therapeutic R&D
Alleo Labs is a preclinical biotech developing first-in-class, brain-penetrant oral therapies for neurodegenerative diseases like Parkinson’s and Alzheimer’s. Using its AI platform, RubDUB™, the company identifies selective small molecules targeting key immune and protein homeostasis pathways. Its lead program is in IND-enabling studies with plans for clinical entry by 2027. Backed by neuroscience and drug discovery experts, Alleo is building a pipeline of disease-modifying therapies with strong partnering potential.
Address
San FranciscoCA
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}